Nocturnal hypoglycaemia in type 1 diabetes - Consequences and assessment

Diabetes/Metabolism Research and Reviews

Volumn 20, Issue SUPPL. 2, 2004, Pages

  DeVries, J Hans ^a   Wentholt, Iris M E ^a   Masurel, Nathalie ^b   Mantel, Itske ^b   Poscia, Alessandro ^c   Maran, Alberto ^d   Heine, Robert J ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Geriatric Department   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

Continuous glucose measurement; Hypoglycaemia; Hypoglycaemia unawareness; Type 1 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

DEVICE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MEDICAL ASSESSMENT; MICRODIALYSIS; PRIORITY JOURNAL; REVIEW; SENSOR; SYMPTOM; WELLBEING;

CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN;

EID: 11144286649     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.513     Document Type: Review

References (16)

1. DCCT research group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329 14): 977-986.
2. Jones TW, Porter P, Sherwin RS, et al. Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med 1998; 338(23): 1657-1662.
3. Gale EA, Tattersall RB. Unrecognised nocturnal hypoglycaemia in insulin-treated diabetics. Lancet 1979; 1(8125): 1049-1052.
4. King P, Kong MF, Macdonald IA, Parkin H, Tattersall RB. Wellbeing, cerebral function, and physical fatigue after nocturnal hypoglycemia in IDDM. Diabetes Care 1998; 21(3): 341-345.
5. Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J. Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes 1993; 42(9): 1233-1237
6. Bendtson I, Kverneland A, Pramming S, Binder C. Incidence of nocturnal hypoglycaemia in insulin-dependent diabetic patients on intensive therapy. Acta Med Scand 1988; 223(6): 543-548.
7. Vervoort G, Goldschmidt HM, van Doorn LG. Nocturnal blood glucose profiles in patients with type 1 diabetes mellitus on multiple (> or = 4) daily insulin injection regimens. Diabet Med 1996; 13 9): 794-799.
8. Bode BW, Gross TM, Thornton KR, Mastrototaro JJ. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract 1999; 46 3): 183-190.
9. Cheyne E, Kerr D. Making 'sense' of diabetes: using a continuous glucose sensor in clinical practice. Diabetes Metab Res Rev 2002; 18(S1): S43-S48.
10. Gross TM, Ter Veer A. Continuous glucose monitoring in previously unstudied population subgroups. Diabetes Technol Ther 2000; 2(Suppl 1): S27-S34.
11. McGowan K, Thomas W, Moran A. Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. Diabetes Care 2002; 25(9): 1499-1503.
12. Monsod TP, Flanagan DE, Rife F, et al. Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia? Diabetes Care 2002; 25(5): 889-893.
13. Mastrototaro JJ, Gross TM. Reproducibility of the continuous glucose monitoring system matches previous reports and the intended use of the product. Diabetes Care 2003; 26(1): 256-257.
14. Gross TM, Mastrototaro JJ. Efficacy and reliability of the continuous glucose monitoring system. Diabetes Technol Ther 2000; 2(Suppl 1): S19-S26.
15. Maran A, Crepaldi C, Tiengo A, et al. Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. Diabetes Care 2002; 25(2): 347-352.
16. DeVries JH, Masurel N, Mantel I. Nocturnal hypoglycaemia is not inevitable in Type 1 diabetes patients on continuous subcutaneous insulin infusion (CSII). Diabetes & Metabolism 2003; 29: 4S230.